Collegium Pharmaceutical, Inc. (COLL) Earnings History
Growth Compounder13 years of earnings data (2013–2025) · Consistent double-digit EPS growth over 5 years
Loading earnings history...
Collegium Pharmaceutical, Inc. (COLL) Earnings Overview
As of June 21, 2026, Collegium Pharmaceutical, Inc. (COLL) reported trailing twelve-month net income of $75M, reflecting -7.0% year-over-year growth. The company earned $1.87 per diluted share over the past four quarters, with a net profit margin of 8.1%.
Looking at the long-term picture, COLL's 5-year EPS compound annual growth rate (CAGR) stands at +17.9%, indicating exceptional earnings growth. The company achieved its highest annual net income of $72M in fiscal 2021.
Collegium Pharmaceutical, Inc. maintains positive profitability with a gross margin of 59.3%, operating margin of 24.0%, and net margin of 8.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including AVDL (-$278,000 net income, -28.9% margin), HRMY ($146M net income, 18.3% margin), SUPN (-$29M net income, -5.4% margin), COLL has outperformed on profitability metrics. Compare COLL vs AVDL →
COLL Earnings vs Peers
Earnings metrics vs comparable public companies
COLL Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $63M | -9.1% | $187M | $1.73 | 8.1% | 24.0% |
| 2024 | $69M | +43.7% | $170M | $1.86 | 11.0% | 26.9% |
| 2023 | $48M | +292.6% | $167M | $1.29 | 8.5% | 29.5% |
| 2022 | -$25M | -135.0% | $33M | $-0.74 | -5.4% | 7.2% |
| 2021 | $72M | +167.3% | $18M | $1.86 | 25.8% | 6.4% |
| 2020 | $27M | +217.7% | $56M | $0.76 | 8.6% | 18.1% |
| 2019 | -$23M | +41.9% | -$24M | $-0.24 | -7.7% | -8.0% |
| 2018 | -$39M | +47.7% | -$21M | $-1.19 | -14.0% | -7.4% |
| 2017 | -$75M | +20.5% | -$75M | $-2.47 | -262.9% | -264.9% |
| 2016 | -$94M | -245.5% | -$94M | $-3.88 | -5504.1% | -5498.7% |
| 2015 | -$27M | -52.1% | -$27M | $-2.01 | - | - |
| 2014 | -$18M | -10.6% | -$18M | $-2.40 | - | - |
| 2013 | -$16M | - | -$16M | $-2.17 | - | - |
Download Data
Export COLL earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
COLL — Frequently Asked Questions
Quick answers to the most common questions about buying COLL stock.
What is COLL earnings per share (EPS)?
COLL trailing twelve-month (TTM) diluted EPS is $1.87, reflecting -7.0% year-over-year growth. The 5-year EPS CAGR is +17.9%. Complete EPS history from 2013 to 2025 is available in the table on this page.
What is Collegium Pharmaceutical, Inc.'s net income?
Collegium Pharmaceutical, Inc. (COLL) trailing twelve-month net income is $75M as of 2025. Earnings declined -7.0% year-over-year. Collegium Pharmaceutical, Inc. has been profitable for 3 consecutive years.
Is COLL profitable?
Yes, COLL is profitable with a TTM net income of $75M and a net profit margin of +8.1%. Collegium Pharmaceutical, Inc. has generated profits for 3 consecutive years.
What is COLL's earnings growth rate?
COLL compound annual EPS growth rates (CAGR): 1-Year: -7.0%, 3-Year: N/A, 5-Year: +17.9%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2025.
What are COLL's profit margins?
Collegium Pharmaceutical, Inc. net profit margin is +8.1%, operating margin is +24.0%, and gross margin is +59.3%. Margins are within a typical range for the sector. Return on Equity is +23.7%.
Is COLL growing earnings?
COLL earnings are declining — EPS fell -7.0% year-over-year. TTM net income dropped to $75M. This contrasts with the 5-year CAGR of +17.9%.
What was COLL's best earnings year?
Collegium Pharmaceutical, Inc.'s highest annual net income on record is $72M, achieved in fiscal year 2021. Earnings history on this page spans 2013 to 2025 and includes all annual and quarterly figures.
What were COLL's earnings last quarter?
COLL's most recent reported quarter was Q1 2026. Net income was $14M with diluted EPS of $0.40. For a full breakdown of all quarters, see the quarterly earnings table on this page.